logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Cancer Drug Resistance by Mark W. Dewhirst DVM, PhD, Yiting Cao MD, PhD, Benjamin Moeller PhD, Chuan-Yuan Li PhD (auth.), Beverly A. Teicher PhD (eds.) ISBN 9781588295309, 9781597450355, 1588295303, 1597450359

  • SKU: EBN-4395810
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

4.6

23 reviews
Instant download (eBook) Cancer Drug Resistance after payment.
Authors:Mark W. Dewhirst DVM, PhD, Yiting Cao MD, PhD, Benjamin Moeller PhD, Chuan-Yuan Li PhD (auth.), Beverly A. Teicher PhD (eds.)
Pages:617 pages.
Year:2006
Editon:1
Publisher:Humana Press
Language:english
File Size:5.38 MB
Format:pdf
ISBNS:9781588295309, 9781597450355, 1588295303, 1597450359
Categories: Ebooks

Product desciption

(Ebook) Cancer Drug Resistance by Mark W. Dewhirst DVM, PhD, Yiting Cao MD, PhD, Benjamin Moeller PhD, Chuan-Yuan Li PhD (auth.), Beverly A. Teicher PhD (eds.) ISBN 9781588295309, 9781597450355, 1588295303, 1597450359

As genomic techniques gradually reveal the ability of malignant cells to respond to chemical and biological insults with remarkable flexibility of phenotype, it becomes clear that much remains to be done to control and eliminate such cells. In Cancer Drug Resistance, leading scientists from the best academic institutions and industrial laboratories summarize and synthesize the latest discoveries concerning the changes that occur in tumor cells as they develop resistance to a wide variety of anticancer therapeutics, as well as suggest new approaches to the biology of drug resistance that may afford new therapeutic opportunities. The authors review physiological resistance based tumor architecture, cellular resistance based on drug transport, epigenetic changes that neutralize or bypass drug cytotoxicity, and genetic changes that alter drug target molecules by decreasing or eliminating drug binding and efficacy. Highlights include new insights into resistance to antiangiogenic therapies, oncogenes and tumor suppressor genes in therapeutic resistance, cancer stem cells, and the development of more effective therapies. There are also new findings on tumor immune escape mechanisms, gene amplification in drug resistance, the molecular determinants of multidrug resistance, and resistance to taxanes and Herceptin®. Authoritative and insightful, Cancer Drug Resistance offers basic and clinical investigators a state-of-the-art synthesis of the many faceted research now available on the biology and genetics of tumor resistance, as well as exciting new approaches to its prevention and eradication.
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products